Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA as Initial Treatment for Active Hemophagocytic Lymphohistiocytosis
NCT07626398Phase 3Not yet recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Jun 2026
- Primary completion
- Jun 2028
01
Overview
A Phase 3 trial of tretinoin in hemophagocytic lymphohistiocytosis (HLH), sponsored by Beijing An Zhen Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
tretinoin
03
Conditions
hemophagocytic lymphohistiocytosis (HLH)
Beyond the preview
Go deeper on NCT07626398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07626398.